Shape change in the receptor for gliding motility in Plasmodium sporozoites

G Song, AC Koksal, C Lu… - Proceedings of the …, 2012 - National Acad Sciences
Sporozoite gliding motility and invasion of mosquito and vertebrate host cells in malaria is
mediated by thrombospondin repeat anonymous protein (TRAP). Tandem von Willebrand …

Experimentally induced blood stage malaria infection as a tool for clinical research

CR Engwerda, G Minigo, FH Amante, JS McCarthy - Trends in parasitology, 2012 - cell.com
A system for experimentally induced blood stage malaria infection (IBSM) with Plasmodium
falciparum by direct intravenous inoculation of infected erythrocytes was developed at the …

Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection

V Offeddu, V Thathy, K Marsh… - International journal for …, 2012 - Elsevier
Malaria is a vector-borne infectious disease caused by infection with eukaryotic pathogens
termed Plasmodium. Epidemiological hallmarks of Plasmodium falciparum malaria are …

Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria

RD Ellis, Y Wu, LB Martin, D Shaffer, K Miura, J Aebig… - 2012 - journals.plos.org
A Phase 1 dose escalating study was conducted in malaria naïve adults to assess the safety,
reactogenicity, and immunogenicity of the blood stage malaria vaccine …

Genetic engineering of attenuated malaria parasites for vaccination

SM Khan, CJ Janse, SHI Kappe… - Current opinion in …, 2012 - Elsevier
Vaccination with live-attenuated Plasmodium sporozoites that arrest in the liver can
completely protect against a malaria infection both in animal models and in humans; this has …

Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine

M Zeeshan, MT Alam, S Vinayak, H Bora, RK Tyagi… - 2012 - journals.plos.org
RTS, S is the most advanced malaria vaccine candidate, currently under phase-III clinical
trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region …

New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodiumfalciparum Agents

N Boechat, LCS Pinheiro, TS Silva, ACC Aguiar… - Molecules, 2012 - mdpi.com
According to the World Health Organization, half of the World's population, approximately
3.3 billion people, is at risk for developing malaria. Nearly 700,000 deaths each year are …

Whole parasite vaccination approaches for prevention of malaria infection

NS Butler, AM Vaughan, JT Harty, SHI Kappe - Trends in immunology, 2012 - cell.com
Malaria is caused by complex protozoan Plasmodium parasites that have foiled efforts to
develop a protective vaccine. Despite this, it has been known for more than 40 years that …

Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease

M Witschel, M Rottmann, M Kaiser… - PLoS neglected tropical …, 2012 - journals.plos.org
In tropical regions, protozoan parasites can cause severe diseases with malaria,
leishmaniasis, sleeping sickness, and Chagas disease standing in the forefront. Many of the …

The Evolutionary Consequences of Blood-Stage Vaccination on the Rodent Malaria Plasmodium chabaudi

VC Barclay, D Sim, BHK Chan, LA Nell, MA Rabaa… - 2012 - journals.plos.org
Malaria vaccine developers are concerned that antigenic escape will erode vaccine efficacy.
Evolutionary theorists have raised the possibility that some types of vaccine could also …